SRBT — Shanrong Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.17m
- $2.04m
- $1.32m
Annual cashflow statement for Shanrong Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 July 31st | 2008 July 31st | 2009 December 31st | |
|---|---|---|---|
| Period Length: | 8 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.053 | -0.04 | -5.08 |
| Depreciation | |||
| Non-Cash Items | 0 | 0.007 | 3.38 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.03 | -0.011 | 0.872 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -0.023 | -0.044 | -0.787 |
| Capital Expenditures | -0.006 | 0 | 0 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -0.006 | 0 | 0 |
| Financing Cash Flow Items | — | — | 0 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.075 | 0 | 0.757 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.046 | -0.045 | -0.031 |